Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 11, 2020
Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosisKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.Cancers|September 9, 2023
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab TreatmentYosuke Tamura, Atsushi Ono, Hikaru Nakahara, et al.Biorxiv : the Preprint Server for Biology|September 21, 2021
Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.Oncology|September 4, 2020
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with LenvatinibYuwa Ando, Tomokazu Kawaoka, Yosuke Suehiro, et al.ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.Oncology|May 4, 2021
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular CarcinomaYuwa Ando, Tomokazu Kawaoka, Kei Amioka, et al.Journal of Medicinal Chemistry|April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L Mackman, Hon C Hui, Michel Perron, et al.Bioorganic & Medicinal Chemistry Letters|March 10, 2017
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable propertiesThorsten A Kirschberg, Sammy Metobo, Michael O Clarke, et al.Oncology|May 17, 2021
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular CarcinomaKensuke Naruto, Tomokazu Kawaoka, Kei Amioka, et al.Liver Cancer|January 29, 2026
Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective StudyKo Hashimoto, Tomokazu Kawaoka, Tomoaki Emori, et al.Pageof 20